Relenza Powder
Product Images NDC 0173-0681

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Relenza (NDC 0173-0681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zanamivir Structural Formula (Relenza Spl Graphic 01)

Chemical structure diagram of zanamivir, the active ingredient in RELENZA 5 mg/1 powder for respiratory inhalation, manufactured by GlaxoSmithKline LLC.*

FDA Label Image

Relenza Logo (Relenza Spl Graphic 02)

An instructional diagram showing the labeled parts of the RELENZA Diskhaler device for inhalation powder. Components identified include the cover, white mouthpiece, dark brown wheel, white tray, raised ridges, needle, Diskhaler body, half-circle flap, and silver medicine disk containing four blisters of medicine.*

FDA Label Image

Parts Of The Diskhaler (Relenza Spl Graphic 03)

An instructional illustration showing a person removing the blue protective cap from a RELENZA inhalation device containing zanamivir powder for respiratory use. A white arrow indicates the direction to pull the cap off the inhaler device.*

FDA Label Image

Step A: Load The Medicine In Diskhaler (Relenza Spl Graphic 04)

An instructional illustration showing a person holding and preparing the RELENZA inhalation device containing zanamivir powder for respiratory use. The image demonstrates the removal or loading process with a white arrow indicating the direction of motion.*

FDA Label Image

Step B: Steps 1, 2, 3, And 4 (Relenza Spl Graphic 05)

An instructional illustration showing hands holding a RELENZA inhaler device labeled with the product name and strength (5 mg). The image highlights the device's ridges and indicates the areas to push for operation, demonstrating the correct handling method for the respiratory powder inhalation product by GlaxoSmithKline LLC.*

FDA Label Image

Step C: Steps 1 And 2 (Relenza Spl Graphic 06)

An instructional illustration showing hands holding a multi-dose inhaler device with one circular blister of RELENZA (zanamivir) powder for respiratory inhalation. The image demonstrates removing the foil cover from the blister for loading into the inhaler device, used to deliver 5 mg doses of zanamivir by inhalation.*

FDA Label Image

Step D: Steps 1 And 2 (Relenza Spl Graphic 07)

An instructional illustration showing hands demonstrating use of the RELENZA inhalation device containing zanamivir powder, with an arrow indicating the direction to operate the device for administration via inhalation.*

FDA Label Image

Relenza Carton (Relenza Spl Graphic 08)

An instructional illustration showing a close-up of a hand holding the DISKHALER device used for RELENZA (zanamivir) powder inhalation. The image includes a text bubble advising to keep the DISKHALER level during use.*

FDA Label Image

Relenza Spl Graphic 09

An instructional illustration showing hands opening the blister containing the RELENZA (zanamivir) powder inhalation device. The image depicts the step of lifting the blister cover to access the powdered dose for respiratory inhalation.*

FDA Label Image

Relenza Spl Graphic 10

An instructional illustration showing hands holding the RELENZA inhalation device for administering zanamivir powder. The image depicts the action of opening or activating the device, indicated by a curved arrow guiding the motion.*

FDA Label Image

Relenza Spl Graphic 11

An illustration showing a woman demonstrating the use of an inhalation device, holding a small inhaler near her mouth and exhaling as part of the inhalation process.*

FDA Label Image

Relenza Spl Graphic 12

An illustration showing a woman using a RELENZA inhalation device, demonstrating how to inhale the powder medication zanamivir through the respiratory route. The image focuses on the proper placement of the device at the mouth for administration.*

FDA Label Image

Relenza Spl Graphic 13

An instructional illustration showing a person holding and pulling apart the two halves of a RELENZA inhalation device to open it. A white arrow indicates the direction to separate the device components for use or assembly.*

FDA Label Image

Relenza Spl Graphic 14

An instructional illustration showing how to hold and press on a RELENZA inhaler device to activate it, with an arrow and the word 'CLICK' indicating the button press action. The hands demonstrate correct finger placement for using the device.*

FDA Label Image

Relenza Spl Graphic 15

Label of RELENZA (zanamivir) inhalation powder, 5 mg per blister, supplied as 5 Relenza Rotadisks with four 5 mg blisters each and one Diskhaler inhalation device. The label includes storage instructions, usage with the Diskhaler device, and states the product is for oral inhalation only. Labeled by GlaxoSmithKline LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.